Korean LNP Tech Firm SURGINEX Raises KRW 8.5 Billion, Expands Global Reach
SURGINEX, a company based in Korea specializing in lipid nanoparticle (LNP) technology, has successfully raised an investment of KRW 8.5 billion....
LSK Investment
SURGINEX, a company based in Korea specializing in lipid nanoparticle (LNP) technology, has successfully raised an investment of KRW 8.5 billion....